A Genome-Wide Linkage Analysis in 181 German Sarcoidosis Families Using Clustered Biallelic Markers


      Sarcoidosis (SA) is a systemic granulomatous inflammatory disorder with complex etiology and strong clustering in families. Genome-wide association studies have been successful in the identification of common risk variants for the disease. To reveal susceptibility variants with low frequencies but strong effects, we performed a genome-wide linkage scan in a large sample of SA families.


      We genotyped 528 members of 181 German SA families for 3,882 single nucleotide polymorphism assays from the SNPlex System Human Linkage Mapping Set 4K.


      Nonparametric linkage analysis revealed one region of suggestive linkage on chromosome 12p13.31 at 20 cM (logarithm of odds [LOD] = 2.53; local P value = .0003) and another linkage peak of nearly suggestive linkage on 9q33.1 at 134 cM (LOD = 2.12; local P value = .0009). The latter has been reported to show suggestive evidence for linkage in a sample of 229 African American SA families previously. Analysis of acute and chronically affected families revealed a subphenotype-specific linkage pattern and an additional, nearly suggestive linkage peak on chromosome 16p13.11 at 38 cM (LOD = 2.09; local P value = .001), which was confined to acute SA.


      Our results propose that the respective regions might harbor yet-unidentified, possibly subphenotype-specific risk factors for the disease (eg, with immune-related functions like the tumor necrosis factor receptor 1). They should be proved to be important for SA pathogenesis and investigated in detail with an emphasis on rare variants. Subphenotype-specific risk factors might serve for prognosis of the clinical course of the disease.
      To read this article in full you will need to make a payment
      Subscribe to CHEST
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Sverrild A
        • Backer V
        • Kyvik KO
        • et al.
        Heredity in sarcoidosis: a registry-based twin study.
        Thorax. 2008; 63: 894-896
        • Statement on Sarcoidosis
        Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999.
        Am J Respir Crit Care Med. 1999; 160: 736-755
        • Zissel G
        • Prasse A
        • Müller-Quernheim J.
        Sarcoidosis—immunopathogenetic concepts.
        Semin Respir Crit Care Med. 2007; 28: 3-14
        • Müller-Quernheim J
        • Schürmann M
        • Hofmann S
        • et al.
        Genetics of sarcoidosis.
        Clin Chest Med. 2008; 29: 391-414
        • Iannuzzi MC
        • Rybicki BA
        • Teirstein AS
        N Engl J Med. 2007; 357: 2153-2165
        • Schürmann M
        • Reichel P
        • Müller-Myhsok B
        • Schlaak M
        • Müller-Quernheim J
        • Schwinger E
        Results from a genome-wide search for predisposing genes in sarcoidosis.
        Am J Respir Crit Care Med. 2001; 164: 840-846
        • Iannuzzi MC
        • Iyengar SK
        • Gray-McGuire C
        • et al.
        Genome-wide search for sarcoidosis susceptibility genes in African Americans.
        Genes Immun. 2005; 6: 509-518
        • Valentonyte R
        • Hampe J
        • Huse K
        • et al.
        Sarcoidosis is associated with a truncating splice site mutation in BTNL2.
        Nat Genet. 2005; 37: 357-364
        • Rybicki BA
        • Walewski JL
        • Maliarik MJ
        • Kian H
        • Iannuzzi MC
        • ACCESS Research Group
        The BTNL2 gene and sarcoidosis susceptibility in African Americans and whites.
        Am J Hum Genet. 2005; 77: 491-499
        • Hofmann S
        • Franke A
        • Fischer A
        • et al.
        Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis.
        Nat Genet. 2008; 40: 1103-1106
        • Franke A
        • Fischer A
        • Nothnagel M
        • et al.
        Genome-wide association analysis in sarcoidosis and Crohn's disease unravels a common susceptibility locus on 10p12.2.
        Gastroenterology. 2008; 135: 1207-1215
        • Iannuzzi MC
        Genetics of sarcoidosis.
        Semin Respir Crit Care Med. 2007; 28: 15-21
        • Risch N
        • Merikangas K
        The future of genetic studies of complex human diseases.
        Science. 1996; 273: 1516-1517
        • Hampe J
        • Franke A
        • Rosenstiel P
        • et al.
        A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1.
        Nat Genet. 2007; 39: 207-211
        • Abecasis GR
        • Wigginton JE
        Handling marker-marker linkage disequilibrium: pedigree analysis with clustered markers.
        Am J Hum Genet. 2005; 77: 754-767
        • Lander E
        • Kruglyak L
        Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results.
        Nat Genet. 1995; 11: 241-247
        • Rybicki BA
        • Major M
        • Popovich Jr, JJ
        • Maliarik MJ
        • Iannuzzi MC
        Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization.
        Am J Epidemiol. 1997; 145: 234-241
        • Rossman MD
        • Thompson B
        • Frederick M
        • ACCESS Group
        • et al.
        HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites.
        Am J Hum Genet. 2003; 73: 720-735
        • Baughman RP
        • Teirstein AS
        • Judson MA
        • Case Control Etiologic Study of Sarcoidosis (ACCESS) research group
        • et al.
        Clinical characteristics of patients in a case control study of sarcoidosis.
        Am J Respir Crit Care Med. 2001; 164: 1885-1889
        • Plenge RM
        • Seielstad M
        • Padyukov L
        • et al.
        TRAF1-C5 as a risk locus for rheumatoid arthritis—a genomewide study.
        N Engl J Med. 2007; 357: 1199-1209
        • Kurreeman FA
        • Goulielmos GN
        • Alizadeh BZ
        • et al.
        The TRAF1-C5 region on chromosome 9q33 is associated with multiple autoimmune diseases.
        Ann Rheum Dis. 2010; 69: 696-699
        • Gasque P
        Complement: a unique innate immune sensor for danger signals.
        Mol Immunol. 2004; 41: 1089-1098
        • Guicciardi ME
        • Gores GJ
        Life and death by death receptors.
        FASEB J. 2009; 23: 1625-1637
        • Waschke KA
        • Villani A-C
        • Vermeire S
        • et al.
        Tumor necrosis factor receptor gene polymorphisms in Crohn's disease: association with clinical phenotypes.
        Am J Gastroenterol. 2005; 100: 1126-1133
        • Zumla A
        • James DG
        Granulomatous infections: etiology and classification.
        Clin Infect Dis. 1996; 23: 146-158
        • Pabst S
        • Karpushova A
        • Dìaz-Lacava A
        • et al.
        VEGF gene haplotypes are associated with sarcoidosis.
        Chest. 2010; 137: 156-163
        • Grunewald J
        • Eklund A
        Löfgren's syndrome: human leukocyte antigen strongly influences the disease course.
        Am J Respir Crit Care Med. 2009; 179: 307-312
        • Fischer A
        • Valentonyte R
        • Nebel A
        • et al.
        Female-specific association of C-C chemokine receptor 5 gene polymorphisms with Löfgren's syndrome.
        J Mol Med. 2008; 86: 553-561
        • Brown L
        • Ongusaha PP
        • Kim H-G
        • et al.
        CDIP, a novel pro-apoptotic gene, regulates TNFalpha-mediated apoptosis in a p53-dependent manner.
        EMBO J. 2007; 26: 3410-3422
        • Swanberg M
        • Lidman O
        • Padyukov L
        • et al.
        MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction.
        Nat Genet. 2005; 37: 486-494
        • Martinez A
        • Perdigones N
        • Cenit M
        • et al.
        Chromosomal region 16p13: further evidence of increased predisposition to immune diseases.
        Ann Rheum Dis. 2010; 69: 309-311
        • Krawczyk M
        • Reith W
        Regulation of MHC class II expression, a unique regulatory system identified by the study of a primary immunodeficiency disease.
        Tissue Antigens. 2006; 67: 183-197
        • Evans DM
        • Cardon LR
        Guidelines for genotyping in genomewide linkage studies: single-nucleotide-polymorphism maps versus microsatellite maps.
        Am J Hum Genet. 2004; 75: 687-692
        • Ulgen A
        • Li W
        Comparing single-nucleotide polymorphism marker-based and microsatellite marker-based linkage analyses.
        BMC Genet. 2005; 6: S13
        • John S
        • Shephard N
        • Liu G
        • et al.
        Whole-genome scan, in a complex disease, using 11,245 single-nucleotide polymorphisms: comparison with microsatellites.
        Am J Hum Genet. 2004; 75: 54-64
        • Middleton FA
        • Pato MT
        • Gentile KL
        • et al.
        Genomewide linkage analysis of bipolar disorder by use of a high-density single-nucleotide-polymorphism (SNP) genotyping assay: a comparison with microsatellite marker assays and finding of significant linkage to chromosome 6q22.
        Am J Hum Genet. 2004; 74: 886-897